+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
177906-48-8,MFCD03001719
Catalog No.:AA0037LP

177906-48-8 | N-Boc-trans-1,4-cyclohexanediamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
97%
in stock  
$3.00   $2.00
- +
25g
95%
in stock  
$56.00   $39.00
- +
50g
95%
in stock  
$108.00   $76.00
- +
100g
95%
in stock  
$215.00   $150.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0037LP
Chemical Name:
N-Boc-trans-1,4-cyclohexanediamine
CAS Number:
177906-48-8
Molecular Formula:
C11H22N2O2
Molecular Weight:
214.3046
MDL Number:
MFCD03001719
SMILES:
N[C@@H]1CC[C@H](CC1)NC(=O)OC(C)(C)C
Properties
Properties
 
BP:
322°C at 760 mmHg  
Form:
Solid  
MP:
74.5 - 75.5 °C  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
215  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.3  

Upstream Synthesis Route

[1]Chemistry-AnAsianJournal,2010,vol.5,#4,p.877-886

[2]Patent:WO2016/160617,2016,A2,.Locationinpatent:Paragraph00401

[3]JournalofOrganicChemistry,1996,vol.61,#25,p.8811-8818

[4]Patent:WO2016/116563,2016,A1,.Locationinpatent:Page/Pagecolumn34-35

[5]Patent:WO2008/57468,2008,A1,.Locationinpatent:Page/Pagecolumn352

[6]Patent:WO2013/134079,2013,A1,.Locationinpatent:Paragraph0176-0177

[7]BioorganicandMedicinalChemistry,2000,vol.8,#6,p.1451-1466

[8]BioorganicandMedicinalChemistryLetters,2004,vol.14,#20,p.5223-5226

[9]Patent:KR2015/83721,2015,A,.Locationinpatent:Page/Pagecolumn18

[10]ChemicalCommunications,2017,vol.53,#6,p.1064-1067

[11]JournalofEnzymeInhibitionandMedicinalChemistry,2017,vol.32,#1,p.865-877

[12]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.655-666

[13]Patent:EP1323710,2003,A1,

[1]Phytochemistry,2003,vol.63,#3,p.315-334

[1]Patent:EP1775298,2007,A1,.Locationinpatent:Page/Pagecolumn33-34

Downstream Synthesis Route

[1]Chemistry-AnAsianJournal,2010,vol.5,p.877-886

[2]Patent:US2020/39979,2020,A1.Locationinpatent:Paragraph0417-0418

[3]Patent:CN110894209,2020,A.Locationinpatent:Paragraph0085;0202;0205;0214

[4]Patent:WO2016/160617,2016,A2.Locationinpatent:Paragraph00401

[5]JournalofOrganicChemistry,1996,vol.61,p.8811-8818

[6]Patent:WO2016/116563,2016,A1.Locationinpatent:Page/Pagecolumn34-35

[7]Patent:WO2008/57468,2008,A1.Locationinpatent:Page/Pagecolumn352

[8]Patent:CN109988172,2019,A.Locationinpatent:Paragraph0030

[9]Patent:WO2013/134079,2013,A1.Locationinpatent:Paragraph0176-0177

[10]BioorganicandMedicinalChemistry,2000,vol.8,p.1451-1466

[11]BioorganicandMedicinalChemistry,2019,vol.27,p.383-393

[12]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.5223-5226

[13]Patent:KR2015/83721,2015,A.Locationinpatent:Page/Pagecolumn18

[14]ChemicalCommunications,2017,vol.53,p.1064-1067

[15]JournalofEnzymeInhibitionandMedicinalChemistry,2017,vol.32,p.865-877

[16]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.655-666

[17]Patent:EP1323710,2003,A1

779-27-1    177906-48-8   
C21H26N2O6 

[1]JournaloftheAmericanChemicalSociety,2007,vol.129,p.10616-10617

[1]Patent:WO2006/20415,2006,A1.Locationinpatent:Page/Pagecolumn105

177906-48-8    7115-91-5   
N-tert-butoxycarbonyl-trans-4-(1-oxo-2-isoindolinyl)cyclohexylamine 

[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-EP1323710,2003,A1

[1]Patent:EP1775298,2007,A1.Locationinpatent:Page/Pagecolumn33-34

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 177906-48-8
1021919-45-8

1021919-45-8

 1023301-84-9

1023301-84-9

 1023595-19-8

1023595-19-8

 1160247-15-3

1160247-15-3

 1163729-53-0

1163729-53-0

 1170905-43-7

1170905-43-7
Building Blocks
More >
Tags:177906-48-8 Molecular Formula|177906-48-8 MDL|177906-48-8 SMILES|177906-48-8 N-Boc-trans-1,4-cyclohexanediamine
Catalog No.: AA0037LP
177906-48-8,MFCD03001719
177906-48-8 | N-Boc-trans-1,4-cyclohexanediamine
Pack Size： 500mg
Purity： 97%
in stock
$3.00 $2.00
Pack Size： 25g
Purity： 95%
in stock
$56.00 $39.00
Pack Size： 50g
Purity： 95%
in stock
$108.00 $76.00
Pack Size： 100g
Purity： 95%
in stock
$215.00 $150.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0037LP
Chemical Name: N-Boc-trans-1,4-cyclohexanediamine
CAS Number: 177906-48-8
Molecular Formula: C11H22N2O2
Molecular Weight: 214.3046
MDL Number: MFCD03001719
SMILES: N[C@@H]1CC[C@H](CC1)NC(=O)OC(C)(C)C
Properties
BP: 322°C at 760 mmHg  
Form: Solid  
MP: 74.5 - 75.5 °C  
Storage: Inert atmosphere;2-8℃;  
Complexity: 215  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.3  
Upstream Synthesis Route
24424-99-5    2615-25-0    177906-48-8 

[1]Chemistry-AnAsianJournal,2010,vol.5,#4,p.877-886

[2]Patent:WO2016/160617,2016,A2,.Locationinpatent:Paragraph00401

[3]JournalofOrganicChemistry,1996,vol.61,#25,p.8811-8818

[4]Patent:WO2016/116563,2016,A1,.Locationinpatent:Page/Pagecolumn34-35

[5]Patent:WO2008/57468,2008,A1,.Locationinpatent:Page/Pagecolumn352

[6]Patent:WO2013/134079,2013,A1,.Locationinpatent:Paragraph0176-0177

[7]BioorganicandMedicinalChemistry,2000,vol.8,#6,p.1451-1466

[8]BioorganicandMedicinalChemistryLetters,2004,vol.14,#20,p.5223-5226

[9]Patent:KR2015/83721,2015,A,.Locationinpatent:Page/Pagecolumn18

[10]ChemicalCommunications,2017,vol.53,#6,p.1064-1067

[11]JournalofEnzymeInhibitionandMedicinalChemistry,2017,vol.32,#1,p.865-877

[12]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.655-666

[13]Patent:EP1323710,2003,A1,

24424-99-5    2615-25-0    177906-48-8 

[1]Phytochemistry,2003,vol.63,#3,p.315-334

5414-19-7    177906-48-8    558442-96-9 

[1]Patent:EP1775298,2007,A1,.Locationinpatent:Page/Pagecolumn33-34

Downstream Synthesis Route
24424-99-5    2615-25-0    177906-48-8 

[1]Chemistry-AnAsianJournal,2010,vol.5,p.877-886

[2]Patent:US2020/39979,2020,A1.Locationinpatent:Paragraph0417-0418

[3]Patent:CN110894209,2020,A.Locationinpatent:Paragraph0085;0202;0205;0214

[4]Patent:WO2016/160617,2016,A2.Locationinpatent:Paragraph00401

[5]JournalofOrganicChemistry,1996,vol.61,p.8811-8818

[6]Patent:WO2016/116563,2016,A1.Locationinpatent:Page/Pagecolumn34-35

[7]Patent:WO2008/57468,2008,A1.Locationinpatent:Page/Pagecolumn352

[8]Patent:CN109988172,2019,A.Locationinpatent:Paragraph0030

[9]Patent:WO2013/134079,2013,A1.Locationinpatent:Paragraph0176-0177

[10]BioorganicandMedicinalChemistry,2000,vol.8,p.1451-1466

[11]BioorganicandMedicinalChemistry,2019,vol.27,p.383-393

[12]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.5223-5226

[13]Patent:KR2015/83721,2015,A.Locationinpatent:Page/Pagecolumn18

[14]ChemicalCommunications,2017,vol.53,p.1064-1067

[15]JournalofEnzymeInhibitionandMedicinalChemistry,2017,vol.32,p.865-877

[16]EuropeanJournalofMedicinalChemistry,2018,vol.150,p.655-666

[17]Patent:EP1323710,2003,A1

779-27-1    177906-48-8   
C21H26N2O6 

[1]JournaloftheAmericanChemicalSociety,2007,vol.129,p.10616-10617

88-73-3    177906-48-8    876589-82-1 

[1]Patent:WO2006/20415,2006,A1.Locationinpatent:Page/Pagecolumn105

177906-48-8    7115-91-5   
N-tert-butoxycarbonyl-trans-4-(1-oxo-2-isoindolinyl)cyclohexylamine 

[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION-EP1323710,2003,A1

5414-19-7    177906-48-8    558442-96-9 

[1]Patent:EP1775298,2007,A1.Locationinpatent:Page/Pagecolumn33-34

Related Products of of 177906-48-8
1021919-45-8
1021919-45-8
1023301-84-9
1023301-84-9
1023595-19-8
1023595-19-8
1160247-15-3
1160247-15-3
1163729-53-0
1163729-53-0
1170905-43-7
1170905-43-7
Building Blocks More >
51421-99-9
51421-99-9
4-Chloro-2-methoxypyrimidine
AA0037P1 | MFCD09025734
2140-76-3
2140-76-3
1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
AA0037SB | MFCD00056054
362-07-2
362-07-2
(17β)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol
AA0037VJ | MFCD00010489
1034924-06-5
1034924-06-5
2-Methylpyrimidine-5-boronic acid
AA0037YT | MFCD07375144
26172-55-4
26172-55-4
5-Chloro-2-methyl-4-isothiazolin-3-one, tech grade, >14% in water. CMI/MI >2.0
AA003820 | MFCD00792550
107-07-3
107-07-3
2-Chloroethanol
AA00385F | MFCD00002829
1095661-17-8
1095661-17-8
4-Aminomethylquinoline, HCl
AA00388S | MFCD05861486
849671-56-3
849671-56-3
Spiro[2.5]oct-6-yl-methanol
AA0038BV | MFCD11501505
676607-31-1
676607-31-1
tert-Butyl spiro[indoline-3,4'-piperidine]-1-carboxylate
AA0038FE | MFCD09266212
625-57-0
625-57-0
O-Ethyl carbamothioate
AA0038IE | MFCD00010027
Submit
© 2017 AA BLOCKS, INC. All rights reserved.